The market size for Penicillins and Streptomycins in dosage form in Canada has shown a general trend of decline from 2013 to 2023, with fluctuations including a notable increase in 2020. In 2023, the market stood at 209.6 million USD. Over the last two years, a decrease of approximately 2.3% per year was observed. During the past five years, the compound annual growth rate (CAGR) averaged about 1.59% annually, reflecting a relatively stable but slightly declining market.
Future trends to watch include the potential impacts of new regulatory measures, shifts in healthcare practices, and the introduction of alternative therapies. Additionally, potential inflationary pressures and changes in supplier dynamics could influence market value. Adoption of new technologies in pharmaceutical manufacturing might offer opportunities for market expansion.
How does Canada rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 7 | 7 Australia | 260,610,000 | 2023 | +1.79% | +1.42% | View data |
| 8 | 8 Vietnam | 256,220,000 | 2023 | +4.62% | +6.03% | View data |
| 9 | 9 Canada | 209,600,000 | 2023 | -2.3% | +1.59% | |
| 10 | 10 Spain | 197,590,000 | 2023 | -1.96% | -2.19% | View data |
| 11 | 11 Poland | 143,340,000 | 2023 | -0.61% | -1.38% | View data |
